Biopharmatis to export CNS drugs to Hong Kong

Published: 2013-05-22 06:56:00

Updated: 2013-05-22 06:56:00

Biopharmatis, an affiliate of Hyundai Pharmaceutical Co., said Tuesday that it has signed an agreement with a new partner of Hong Kong to export Hyundai’s CNS (central nervous system)-related two medicines, Multapin tablets (mirtazapine) and Olapin tablets (olanzapine) for the next three years.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK